These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 609579)

  • 1. The effect of intracerebral 6-hydroxy dopamine on 3H-reserpine binding to different brain regions of the rat.
    Mennini T; Bernasconi S; Manara L; Samanin R; Serra G
    Pharmacol Res Commun; 1977 Oct; 9(9):857-62. PubMed ID: 609579
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 3. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intraventricular administration of noradrenaline and dopamine on the levels of corticosterone in rats and denervation hypersensitivity resulting from intraventricular administration of 6-hydroxydopamine.
    Kawa A; Taniguchi Y; Mizuguchi K; Ryu S; Ariyama T; Kamisaki T; Koreeda F; Kanehisa T
    Life Sci; 1978 Sep; 23(9):991-7. PubMed ID: 703530
    [No Abstract]   [Full Text] [Related]  

  • 6. 6-Hydroxydopamine and avoidance: Possible role of response suppression.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):873-8. PubMed ID: 1208629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on homeostasis of intraventricular injections of 6-hydroxydopamine in rats.
    Stricker EM; Zigmond MJ
    J Comp Physiol Psychol; 1974 Jun; 86(6):973-94. PubMed ID: 4836848
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiological and behavioral effects of centrally-administered 6-hydroxydopamine in cats.
    Howard JL; Breese GR
    Pharmacol Biochem Behav; 1974; 2(5):651-61. PubMed ID: 4431828
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of pargyline, reserpine and neurotoxin lesions on [3H]tryptamine binding sites in rat brain.
    Cascio CS; Kellar KJ
    Eur J Pharmacol; 1986 Jan; 120(1):101-5. PubMed ID: 3948908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra- and extraneuronal formation of the two major noradrenaline metabolites in the cns of rats.
    Braestrup C; Nielsen M
    J Pharm Pharmacol; 1975 Jun; 27(6):413-9. PubMed ID: 237089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]Harmaline as a specific ligand of MAO A--II. Measurement of the turnover rates of MAO A during ontogenesis in the rat brain.
    Nelson DL; Herbet A; Glowinski J; Hamon M
    J Neurochem; 1979 Jun; 32(6):1829-36. PubMed ID: 448371
    [No Abstract]   [Full Text] [Related]  

  • 12. Uptake of (-) 3H-norepinephrine by storage vesicles prepared from whole rat brain: properties of the uptake system and its inhibition by drugs.
    Seidler FJ; Kirksey DF; Lau C; Whitmore WL; Slotkin TA
    Life Sci; 1977 Oct; 21(8):1075-85. PubMed ID: 21338
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of intracisternal 6-hydroxydopamine treatment on acquisition and performance of rats in a double T-maze.
    Howard JL; Grant LD; Breese GR
    J Comp Physiol Psychol; 1974 Jun; 86(6):995-1007. PubMed ID: 4836849
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of 6-hydroxydopamine and some hypotensive drugs on lypressin induced hypertension in rats.
    Szadowska A; Szmigielska H; Szmigielski A; Kamińska A; Wejman I
    Pol J Pharmacol Pharm; 1985; 37(4):487-93. PubMed ID: 3936030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of 3-methoxy-4-hydroxyphenylglycol sulfate in rats after intraventricular injection of 6-OHDA.
    Bareggi SR; Marc V; Morselli PL
    Brain Res; 1974 Jul; 75(1):177-80. PubMed ID: 4842814
    [No Abstract]   [Full Text] [Related]  

  • 16. Melanotropic activity in extrahypophyseal regions of rodent brain: effect of age, hormones, and drugs.
    Rudman D; Chawla RK; Katra BS
    Am J Physiol; 1975 Apr; 228(4):1245-8. PubMed ID: 124136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal degeneration caused by lateral ventricular injection of 6-hydroxy-dopamine. I. The ventral premammillary nucleus and other cell groups.
    Hedreen J
    Brain Res; 1978 Nov; 157(1):129-35. PubMed ID: 81096
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of intraventricular injections of 6-hydroxydopamine in neonatal rats on the catecholamine levels and tyrosine hydroxylase activity in brain regions at maturity.
    Peters DA; Pappas BA; Taub H; Saari M
    Biochem Pharmacol; 1977 Dec; 26(23):2211-5. PubMed ID: 22332
    [No Abstract]   [Full Text] [Related]  

  • 19. Tyrosine hydroxylase activity in brain regions after intraventricular 6-hydroxydopamine in the neonatal rat.
    Peters DA; Pappas BA; Taub H; Saari M
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):161-4. PubMed ID: 28554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.